Dr. I.M. Bennani-Baiti
President
Cancer Epigenetics Society
Austria
Biography
Dr. I.M. Bennani-Baiti currently serves as the Executive Editor of Cancer Epigenetics and Clinical Cancer Epigenetics. Dr. Bennani-Baiti has longstanding interests in pediatric cancer, epigenetics, epigenomics, chemistry, and biomathematics. He has extensive experience in reviewing and editing research papers, serving since 2009 as Executive Editor or Editor to nine biomedical journals, and as a Reviewer to more than a dozen other journals. AUniversity of Pennsylvania School of Medicine Human Genetics Fellow, he is also a Howard Hughes scholar who served on the Faculty of St. Louis University School of Medicine under the chairmanship of Dr. William Sly, a member of theNational Academy of Sciences, USA, who characterized the syndrome named after him. Other tenures include theMemorial Sloan-Kettering Cancer Center in New York alongside Dr. Mark Ptashne, Lasker Award laureate and member of the National Academy of Sciences, USA. Dr. Bennani-Baiti is a member of the Society for Mathematical Biology, the American Chemical Society, and the AACR Pediatric Cancer Working Group. He is also a member of the New York Academy of Sciences, USA, and President of the Cancer Epigenetics Society (https://ces.b2sg.org).
Research Interest
Dr. I.M. Bennani-Baiti is interested in all aspects of epigenetics research that may have a bearing on cancer biology, diagnosis, management, or treatment. He is also interested in bioinformatics methods that enable inference of biological significance from underpowered studies, as well as mathematical algorithms that help query cell signaling and gene networks directly in patient samples.